D. Mark Durcan, a director at Cencora, Inc. (NYSE:COR), purchased company common stock valued at $1,065,040 on May 28, 2026.
The transaction involved the acquisition of 4,000 shares at a price of $266.26 per share. Following this purchase, Mr. Durcan directly holds 27,767 shares of Cencora common stock.
The insider purchase comes as the healthcare giant, with a market cap of $52 billion, trades below its Bond.az Fair Value, suggesting potential upside. The stock has declined 21% year-to-date despite the company’s track record of raising dividends for 21 consecutive years.
